A roundtable on responsible innovation with autologous stem cells in Australia, Japan and Singapore-Reference-Cited by-同舟云学术

A roundtable on responsible innovation with autologous stem cells in Australia, Japan and Singapore

Published:2018-09 Issue:9 Volume:20 Page:1103-1109
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

LYSAGHT TAMRA^ORCID,MUNSIE MEGAN,CASTRICUM ADAM,HUI JAMES H.P.,OKADA KYOSHI,SATO YOJI,SAWA YOSHIKI,STEWART CAMERON,TAN LIP KUN,TAN LYNN H.Y.,SUGII SHIGEKI^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference36 articles.

1. The global landscape of stem cell clinical trials;Li;Regenerative Medicine,2013

2. Clinical Trials With Mesenchymal Stem Cells: An Update;Squillaro;Cell Transplantation,2016

3. Ethics and Law for the Health Professional;Kerridge,2013

4. Ethical and Regulatory Challenges with Autologous Adult Stem Cells: A Comparative Review of International Regulations;Lysaght;Journal of Bioethical Inquiry,2017

5. Global Distribution of Businesses Marketing Stem Cell-Based Interventions;Berger;Cell Stem Cell,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and opportunities for access to Advanced Therapy Medicinal Products in Brazil;Cytotherapy;2024-08

2. Scientific venturing for early-stage professionals (ESPs), a key concept in the innovation ecosystem;Cytotherapy;2023-04

3. Ethical, Legal, and Social Implications (ELSI) Research: Methods and Approaches;Current Protocols;2022-01

4. Perspectives on Challenges to Cell Therapy Development in Taiwan: Strengthening Evidential Standards and Ways Forward;Frontiers in Bioengineering and Biotechnology;2021-12-16

5. Australian regulation of autologous human cell and tissue products: implications for commercial stem cell clinics;Regenerative Medicine;2020-02